The share of this pharmaceutical company fell by 0.17 percent after the company announced to exit from one of the manufacturing units in Bangalore. 

Astrazeneca Pharma India Ltd is a small-cap with a market capitalization of Rs 11,615.00 crore, On Friday the company shares were trading at Rs 4,646 a share, a decrease of 0.16 percent from the previous close price. 

According to the exchange filing, Astrazeneca Pharma India Ltd announced to exit from one of the manufacturing units in Bangalore, the Company will put the manufacturing site up for sale in a fully operational manner and start looking for a buyer who can also serve as a Contract Manufacturing Organization (CMO) for the Company’s products that are currently manufactured or packaged at this site. 

Looking into the company’s financials, the company’s revenue increased by 32 percent from Rs 236.13 crore Q2FY23 to Rs 311.07 crore Q2FY24. Further, During the same period, net profit increased by 61 percent from Rs 32.57 crores to Rs 52.37 crores. 

Astrazeneca Pharma India Ltd reported return ratios in the recent financial year with a return on equity (ROE) of 18.13 percent and a return on capital employed (ROCE) of 24.49 percent. 

Astrazeneca Pharma India Ltd’s recent shareholding pattern, The Promoters of the company own 75 percent while Retail shareholders own a 19.9 percent stake in the company and Foreign Institutional Investors own a 2.69 percent stake. 

The stock has delivered a return of 40.87 percent in six months and 40.12 percent in a year. 

Astrazeneca Pharma India Ltd is engaged in the business of manufacturing, distribution, and marketing of pharmaceutical products. 

Written By :- Abhishek Singh